Paper · 35736631

Cancer treatment and survivorship statistics, 2022.

Miller KD and 7 others. CA Cancer J Clin, 2022. Cited by 2,423 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Cancer treatment and survivorship statistics, 2022. Papers, record 35736631. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35736631

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Cancer treatment and survivorship statistics, 2022.; PubMed
Journal: CA Cancer J Clin; PubMed
Year: 2022; PubMed
Publication types: Journal Article, Research Support, Non-U.S. Gov't; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/35736631/; PubMed
DOI: https://doi.org/10.3322/caac.21731; PubMed
The journal: https://conductscience.org/library/journal-index/0370647; PubMed
Citations, by iCite: 2,423; iCite
Relative citation ratio, by iCite: 212; iCite
Revised in PubMed: 2025-07-28; PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	ORCID iD
1	Miller KD	Kimberly D	https://orcid.org/0000-0002-2609-2260
2	Nogueira L	Leticia	https://orcid.org/0000-0001-6990-3660
3	Devasia T	Theresa
4	Mariotto AB	Angela B
5	Yabroff KR	K Robin
6	Jemal A	Ahmedin
7	Kramer J	Joan
8	Siegel RL	Rebecca L	https://orcid.org/0000-0001-5247-8522

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Carcinoma, Non-Small-Cell Lung	Major topic
Lung Neoplasms	Major topic
American Cancer Society
Female
Humans
Male
National Cancer Institute (U.S.)
Survivorship
United States

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials6

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

Trial	Title	The trial lists it as	Source
NCT05976893	Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer	Results	ClinicalTrials.gov
NCT06189547	Impact of 10 Different Prior Cancer History on Survival of Patients Who Underwent Surgery for Second Primary Colorectal Cancer: a Population-based Cohort Study	Background	ClinicalTrials.gov
NCT06582498	Short Questionnaire to Assess Individual Needs in Cancer Survivors in a Clinical Setting	Background	ClinicalTrials.gov
NCT06993987	Study of Interactions Between Oncologists and Resuscitators to Optimize Decision Making for Admission of Patients With Metastatic Solid Cancer to the ICU (InterOncoRea)	Results	ClinicalTrials.gov
NCT07214441	Evaluating the Feasibility and Preliminary Effects of BE+	Background	ClinicalTrials.gov
NCT07743190	A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs)	Background	ClinicalTrials.gov

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

Kind	PMID	Title	In Papers
Comment in	37,882,770	Navigating uncertainties: recurrence challenges in early-stage non-small-cell adenocarcinoma.	https://conductscience.org/library/papers/37882770

Source PubMed

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by1,743

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,423 citations.

PMID	Title	Journal	Year	In Papers	Source
42,970,590	Cohort Profile: The Adolescent and Young Adult Tracking Engagement and Management Skills (AYA TEAMS) longitudinal cohort of childhood cancer survivors in the United States.	PLoS One	2026	https://conductscience.org/library/papers/42970590	PubMed
42,964,164	Synthetic preimplantation factor ameliorates the severity of radiotherapy-induced heart disease in a rat model.	Front Cardiovasc Med	2026	https://conductscience.org/library/papers/42964164	PubMed
42,952,550	Barriers to survivorship care for adolescent and young adult cancer survivors: perspectives of survivors and cancer specialists.	Front Oncol	2026	https://conductscience.org/library/papers/42952550	PubMed
42,952,549	Prevalence of anxiety and depression in breast cancer patients: a meta-analysis.	Front Psychol	2026	https://conductscience.org/library/papers/42952549	PubMed
42,952,150	Disability, community participation, and life satisfaction in working-age cancer survivors.	J Rehabil Med	2026	https://conductscience.org/library/papers/42952150	PubMed
42,940,561	Effects of Model-Based Sexual Counseling on Sexual Function and Sexual Life in Women with Breast Cancer: A Systematic Review and Meta-Analysis.	Healthcare (Basel)	2026	https://conductscience.org/library/papers/42940561	PubMed
42,935,705	Integrative genomics and experimental validation identify a mechanosensitive gene signature associated with colorectal cancer liver metastasis.	iScience	2026	https://conductscience.org/library/papers/42935705	PubMed
42,935,158	IGF1R Induces ROS Formation in Mitochondria via MICU1 Leads to the Enzalutamide Resistance in Prostate Cancer.	J Cell Mol Med	2026	https://conductscience.org/library/papers/42935158	PubMed
42,934,609	Self-management dimensions associated with physical activity participation among gynecological cancer survivors: a cross-sectional study from the international InCHARGE consortium.	BMC Womens Health	2026	https://conductscience.org/library/papers/42934609	PubMed
42,920,861	Genesis-progression of early jaw osteoradionecrosis in head and neck cancer survivors: dynamics of independent but interconnected factors.	Front Oncol	2026	https://conductscience.org/library/papers/42920861	PubMed

1 to 10 of 1,743

See all 1,743 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

Drug	ChEMBL ID	The trials list it as	Trials	In Drugs and targets
EVOLOCUMAB	CHEMBL2364655	Results	1	https://conductscience.org/library/drugs/CHEMBL2364655

Source ChEMBL

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35736631

GET https://conductscience.org/api/papers/v1/35736631/cited_by?page=2

API reference For AI assistants